SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017062
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:57
Documents
56
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20240331_10q.htm   iXBRL 10-Q 869291
2 EXHIBIT 31.1 ex_615111.htm EX-31.1 12826
3 EXHIBIT 31.2 ex_615112.htm EX-31.2 12803
4 EXHIBIT 32.1 ex_615113.htm EX-32.1 4899
5 EXHIBIT 32.2 ex_615114.htm EX-32.2 4867
  Complete submission text file 0001437749-24-017062.txt   4825804

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240331.xsd EX-101.SCH 52222
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20240331_cal.xml EX-101.CAL 22578
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240331_def.xml EX-101.DEF 340569
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240331_lab.xml EX-101.LAB 302262
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240331_pre.xml EX-101.PRE 363087
60 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240331_10q_htm.xml XML 657900
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 24950976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)